Navigation Links
ACE Inhibitor as Effective as More Expensive Blood Pressure Drug
Date:3/31/2008

ient population," McMurray noted.

During a median follow-up time of 56 months, the incidence of deaths and adverse events was almost identical in the two groups -- 16.5 percent for those taking ramipril and 16.7 percent in the telmisartan group. It was also about the same in a group prescribed both medications, 16.3 percent, but there was a higher incidence of side effects such as abnormally low blood pressure and kidney problems among those taking the combination drug therapy.

ARBs still have a place in treatment of high-risk people such as those in the study, Yusuf said. "About 20 to 30 percent of people who take ACE inhibitors have side effects that make them stop," he said. The most common side effect is cough.

"On the other hand, ARBs seem to be valuable when added to an ACE inhibitor in patients with heart failure," McMurray said. The new study group did not include people with heart failure.

Switching from an ARB to an ACE inhibitor can reduce the cost of medical care, Yusuf said. Pill for pill, the cost of an ARB is about 20 percent higher than for an ACE inhibitor in Canada, he said.

More information

Learn more about ACE inhibitors, ARBs and other drugs for high blood pressure from the American Heart Association.



SOURCES: Salim Yusuf, M.D., professor, medicine, McMaster University, Hamilton, Ontario; John J.V. McMurray, M.D., professor, medical cardiology, University of Glasgow, Scotland; March 31, 2008, presentation, American College of Cardiology annual meeting, Chicago; April 10, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
2. Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer
3. Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
4. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
5. S*BIOs Oral JAK2 Inhibitor SB1518 Demonstrates Therapeutic Potential for the Treatment of Myeloproliferative and Other Hematological Disorders
6. Silencing small but mighty cancer inhibitors
7. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
8. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
9. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
10. Impending FDA Approval Decision on the First HIV Integrase Inhibitor Can Have Significant Impact for Patients
11. Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ACE Inhibitor as Effective as More Expensive Blood Pressure Drug
(Date:8/28/2015)... ... 29, 2015 , ... Rio Salado College joined nine educational institutions ... part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded ... Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed to ...
(Date:8/28/2015)... ... 28, 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth ... are applying for, they are unable to pass the initial drug test and therefore ... policies in order to be able to hire long-term, skilled talent. (1) Will Wesch, ...
(Date:8/28/2015)... Falls Church, VA (PRWEB) , ... ... ... and Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and ... – Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... who might personally be struggling with chemical dependency, may be able to find ... Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. Focusing ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol ... Strawbridge, gives a new approach on solutions in his new book ":Unraveling The ... and employees getting together for meaningful group meetings. "This would educate the employees ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Data Can Be Integrated with Other Sales & ... Key Performance Indicators, Dynamic Graphs, And Custom Metrics ... leader in pharmaceutical data analysis and reporting solutions, ... within InView, the company,s graphical interactive portal for ...
... April 29 New analyses of data from ... beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented ... Annual Meeting. The study results showed that ... participants with multiple sclerosis (MS) were more likely ...
... warns more deaths are likely , , WEDNESDAY, April 29 ... become the first U.S. fatality in the spreading swine ... Dr. Richard Besser, acting director of the U.S. Centers ... other details on the case were immediately available, according ...
... Diluted Earnings per Share were $0.89, , Consistent ... Excluding Certain Significant Items, Increased 1% to $0.95- Worldwide ... , Increased 2%, Excluding the Impact of Foreign Exchange ... , Exchange, was Driven by Increases of 23% ...
... vs. $25.2 million - Increase of 34%Record Quarterly Diluted EPS: $0.17 vs. ... OWINGS MILLS, Md., April 29 Medifast, Inc. (NYSE: MED ... 31, 2009. First Quarter highlights included: , , ... quarter revenues increased 34% compared to 2008 to $33.7 million; , ...
... consider healthy hearing for spring 2009 , ... Stäfa, ... spring marks an opportunity for Americans to refresh and revitalize themselves. ... global initiative to inform and educate the public about the importance ...
Cached Medicine News:Health News:Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 3Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 4Health News:U.S. Reports First Swine Flu Death 2Health News:U.S. Reports First Swine Flu Death 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 2Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 5Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 6Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 7Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 8Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 9Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 10Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 11Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 12Health News:Medifast Reports Record First Quarter 2009 Financial Results 2Health News:Medifast Reports Record First Quarter 2009 Financial Results 3Health News:Medifast Reports Record First Quarter 2009 Financial Results 4Health News:Medifast Reports Record First Quarter 2009 Financial Results 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 6Health News:Medifast Reports Record First Quarter 2009 Financial Results 7Health News:Medifast Reports Record First Quarter 2009 Financial Results 8Health News:Medifast Reports Record First Quarter 2009 Financial Results 9Health News:This Spring, Hear the World 2Health News:This Spring, Hear the World 3
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
(Date:8/28/2015)... -- The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic ... & by Region ( North America , ... Rest of the World) - Global Trends and Forecast to ... valued at USD 4.62 Billion in 2014 and is projected ... of 7.4% from 2015 to 2020. Browse ...
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... workstations is designed for laboratories with limited ... automation platform for routine sample preparation and ... throughput, process consistency and safety. Windows ... you to control the robotic and liquid ...
... The Labcyte miniGene LD is a ... to 96-, 384- and 1536-well microplates. This ... 16 channel standard or wide orifice nozzle ... movement allow for accurate dispensing to a ...
... The QFill2 is the ideal system for fast, ... The pressure driven, pinch valve controlled dispensing mechanism, ... Whilst all of the components that come into ... dismantle, clean, and autoclave. The unique compact design ...
... an innovative reagent dispenser for plate ... fulfill the need for precise automated ... more, FlexDrop provides an efficient solution ... tedious task of plate preparation for ...
Medicine Products: